Everest Organics Ltd.
BSE: 524790 | Sector: Health care |
NSE: N.A. | ISIN Code: INE334C01029 |
BSE 00:00 | 27 May | 161.10 |
8.95 (5.88%) |
OPEN
152.95 |
HIGH
165.40 |
LOW
152.95 |
NSE 05:30 | 01 Jan | Everest Organics Ltd Not listed in NSE |
OPEN | 152.95 |
PREVIOUS CLOSE | 152.15 |
VOLUME | 1668 |
52-Week high | 447.90 |
52-Week low | 150.00 |
P/E | 42.17 |
Mkt Cap.(Rs cr) | 129 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Everest Organics Ltd.
Everest Organics was incorporated at Hyderabad in Feb.'93. It was promoted by S K Srihari Raju and S K Chittiramabhadra Raju. The company set up a plant at Aroor Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project.Commercial production of ciprofloxacin and omerprazole commenced in Feb.'96. The company preferred to manufa...> More
Everest Organics Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
129 | |
EPS - TTM | (![]() |
[*S] | 3.82 |
P/E Ratio | (X) | [*S] | 42.17 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | 10.00 | |
Latest Dividend Date | 08 Sep 2021 | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 58.29 |
P/B Ratio | (![]() |
[*S] | 2.76 |
Announcement
-
Audited Financial Results For The Fourth Quarter And Financial Year Ended 31.03.2022
-
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
Everest Organics Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 55.1 | 45.04 | 22.34 |
Other Income | 0.45 | 0.25 | 80 |
Total Income | 55.54 | 45.29 | 22.63 |
Total Expenses | 53.36 | 40.72 | 31.04 |
Operating Profit | 2.19 | 4.57 | -52.08 |
Net Profit | 0.29 | 2.2 | -86.82 |
Equity Capital | 8 | 8 | - |
Everest Organics Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Alpa Laboratorie | 69.80 | -0.21 | 146.86 |
Vikram Thermo | 46.35 | -11.71 | 145.35 |
Samrat Pharma | 422.90 | 4.03 | 130.68 |
Everest Organics | 161.10 | 5.88 | 128.88 |
Bharat Immunolog | 27.10 | -4.07 | 117.02 |
Parnax Lab | 118.85 | 4.25 | 116.59 |
Shree Ganesh Bio | 2.89 | 7.04 | 115.20 |
Everest Organics Ltd - SHAREHOLDING PATTERN
|
|
Everest Organics Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -1.56% | NA | 1.03% | 0.53% |
1 Month | -14.72% | NA | -4.31% | -4.93% |
3 Month | -23.88% | NA | -1.74% | -1.84% |
6 Month | -40.78% | NA | -3.89% | -3.96% |
1 Year | -61.51% | NA | 7.37% | 6.62% |
3 Year | -1.20% | NA | 38.31% | 37.13% |
Everest Organics Ltd - STOCK STRENGTH
Today's Low/High | 152.95 | 165.40 | |
Week Low/High | 150.00 | 179.00 | |
Month Low/High | 150.00 | 197.00 | |
YEAR Low/High | 150.00 | 448.00 | |
All TIME Low/High | 0.75 | 470.00 |
Quick Links for Everest Organics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices